Literature DB >> 22226375

Factors associated with the persistence and onset of new anxiety disorders in youth with bipolar spectrum disorders.

Regina Sala1, David A Axelson, Josefina Castro-Fornieles, Tina R Goldstein, Benjamin I Goldstein, Wonho Ha, Fangzi Liao, Mary Kay Gill, Satish Iyengar, Michael A Strober, Shirley Yen, Heather Hower, Jeffrey I Hunt, Daniel P Dickstein, Neal D Ryan, Martin B Keller, Boris Birmaher.   

Abstract

OBJECTIVE: Anxiety disorders are among the most common comorbid conditions in youth with bipolar disorder, but, to our knowledge, no studies examined the course of anxiety disorders in youth and adults with bipolar disorder.
METHOD: As part of the Course and Outcome of Bipolar Youth study, 413 youth, ages 7 to 17 years who met criteria for Diagnostic and Statistical Manual, Fourth Edition (DSM-IV) bipolar I disorder (n = 244), bipolar II disorder (n = 28), and operationally defined bipolar disorder not otherwise specified (n = 141) were recruited primarily from outpatient clinics. Subjects were followed on average for 5 years using the Longitudinal Interval Follow-Up Evaluation. We examined factors associated with the persistence (> 50% of the follow-up time) and onset of new anxiety disorders in youth with bipolar disorder.
RESULTS: Of the 170 youth who had anxiety at intake, 80.6% had an anxiety disorder at any time during the follow-up. Most of the anxiety disorders during the follow-up were of the same type as those present at intake. About 50% of the youth had persistent anxiety, particularly generalized anxiety disorder (GAD). Persistence was associated with multiple anxiety disorders, less follow-up time in euthymia, less conduct disorder, and less treatment with antimanic and antidepressant medications (all P values ≤ .05). Twenty-five percent of the sample who did not have an anxiety disorder at intake developed new anxiety disorders during follow-up, most commonly GAD. The onset of new anxiety disorders was significantly associated with being female, lower socioeconomic status, presence of attention-deficit/hyperactivity disorder and substance use disorder, and more follow-up time with manic or hypomanic symptoms (all P values ≤ .05)
CONCLUSIONS: Anxiety disorders in youth with bipolar disorder tend to persist, and new-onset anxiety disorders developed in a substantial proportion of the sample. Early identification of factors associated with the persistence and onset of new anxiety disorders may enable the development of strategies for treatment and prevention. © Copyright 2012 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226375      PMCID: PMC3600866          DOI: 10.4088/JCP.10m06720

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  53 in total

1.  Prevalence, subtypes, and correlates of DSM-IV conduct disorder in the National Comorbidity Survey Replication.

Authors:  Matthew K Nock; Alan E Kazdin; Eva Hiripi; Ronald C Kessler
Journal:  Psychol Med       Date:  2006-01-26       Impact factor: 7.723

2.  Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.

Authors:  M W Otto; N M Simon; S R Wisniewski; D J Miklowitz; J N Kogan; N A Reilly-Harrington; E Frank; A A Nierenberg; L B Marangell; K Sagduyu; R D Weiss; S Miyahara; M E Thas; G S Sachs; M H Pollack
Journal:  Br J Psychiatry       Date:  2006-07       Impact factor: 9.319

3.  Phenomenology of children and adolescents with bipolar spectrum disorders.

Authors:  David Axelson; Boris Birmaher; Michael Strober; Mary Kay Gill; Sylvia Valeri; Laurel Chiappetta; Neal Ryan; Henrietta Leonard; Jeffrey Hunt; Satish Iyengar; Jeffrey Bridge; Martin Keller
Journal:  Arch Gen Psychiatry       Date:  2006-10

Review 4.  Vulnerability factors for anxiety disorders in children and adolescents.

Authors:  Kathleen Ries Merikangas
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2005-10

5.  Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode.

Authors:  Melissa P DelBello; Dennis Hanseman; Caleb M Adler; David E Fleck; Stephen M Strakowski
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

6.  Substance use disorders among adolescents with bipolar spectrum disorders.

Authors:  Benjamin I Goldstein; Michael A Strober; Boris Birmaher; David A Axelson; Christianne Esposito-Smythers; Tina R Goldstein; Henrietta Leonard; Jeffrey Hunt; Mary Kay Gill; Satish Iyengar; Colleen Grimm; Mei Yang; Neal D Ryan; Martin B Keller
Journal:  Bipolar Disord       Date:  2008-06       Impact factor: 6.744

Review 7.  Anxiety symptoms and syndromes in bipolar children and adolescents.

Authors:  Edith M Jolin; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2008-04       Impact factor: 5.285

8.  The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder.

Authors:  Benjamin I Goldstein; Anthony J Levitt
Journal:  Bipolar Disord       Date:  2008-02       Impact factor: 6.744

9.  Clinical and research implications of panic-bipolar comorbidity in children and adolescents.

Authors:  Gabriele Masi; Giulio Perugi; Stefania Millepiedi; Cristina Toni; Maria Mucci; Nicoletta Bertini; Chiara Pfanner; Stefano Berloffa; Cinzia Pari; Kareen Akiskal; Hagop S Akiskal
Journal:  Psychiatry Res       Date:  2007-06-28       Impact factor: 3.222

10.  Juvenile mental health histories of adults with anxiety disorders.

Authors:  Alice M Gregory; Avshalom Caspi; Terrie E Moffitt; Karestan Koenen; Thalia C Eley; Richie Poulton
Journal:  Am J Psychiatry       Date:  2007-02       Impact factor: 18.112

View more
  7 in total

1.  Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population.

Authors:  Regina Sala; Benjamin I Goldstein; Carmen Morcillo; Shang-Min Liu; Mariela Castellanos; Carlos Blanco
Journal:  J Psychiatr Res       Date:  2012-04-24       Impact factor: 4.791

2.  Childhood factors associated with increased risk for mood episode recurrences in bipolar disorder-A systematic review.

Authors:  Xavier Estrada-Prat; Anna R Van Meter; Ester Camprodon-Rosanas; Santiago Batlle-Vila; Benjamin I Goldstein; Boris Birmaher
Journal:  Bipolar Disord       Date:  2019-05-15       Impact factor: 6.744

3.  Distinguishing Bipolar Depression from Unipolar Depression in Youth: Preliminary Findings.

Authors:  Rasim Somer Diler; Tina R Goldstein; Danella Hafeman; John Merranko; Fangzi Liao; Benjamin I Goldstein; Heather Hower; Mary Kay Gill; Jeffrey Hunt; Shirley Yen; Martin B Keller; David Axelson; Michael Strober; Satish Iyengar; Neal D Ryan; Boris Birmaher
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-02-28       Impact factor: 2.576

4.  Anxiety disorders and rapid cycling: data from a cohort of 8129 youths with bipolar disorder.

Authors:  Ruby Castilla-Puentes; Regina Sala; Bernardo Ng; Juan Galvez; Alvaro Camacho
Journal:  J Nerv Ment Dis       Date:  2013-12       Impact factor: 2.254

5.  Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders.

Authors:  Regina Sala; Michael A Strober; David A Axelson; Mary Kay Gill; Josefina Castro-Fornieles; Tina R Goldstein; Benjamin I Goldstein; Wonho Ha; Fangzi Liao; Satish Iyengar; Shirley Yen; Heather Hower; Jeffrey Hunt; Daniel P Dickstein; Neal D Ryan; Martin B Keller; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-10-17       Impact factor: 8.829

6.  Comorbid Bipolar Disorder and Obsessive-Compulsive Disorder: An Old Debate Renewed.

Authors:  Andrea Amerio; Matteo Tonna; Anna Odone; S Nassir Ghaemi
Journal:  Psychiatry Investig       Date:  2016-05-18       Impact factor: 2.505

Review 7.  What Do We Know about the Long-Term Course of Early Onset Bipolar Disorder? A Review of the Current Evidence.

Authors:  Carlotta Cirone; Ilaria Secci; Irene Favole; Federica Ricci; Federico Amianto; Chiara Davico; Benedetto Vitiello
Journal:  Brain Sci       Date:  2021-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.